The Global Oncology Information Systems Market Growth Is Accelerated By Increased Adoption Of Advanced Technologies
 |
| Oncology Information Systems Market |
Oncology information systems are computer-based information
systems designed to manage medical and clinical data related to cancer and
oncology. These systems help in maintaining accurate and complete medical
records of cancer patients and also enhance administrative workflow and
regulatory compliance. These systems allow oncologists and healthcare providers
to view medical history, lab results, imaging scans, treatment plans, clinical
notes and follow-up appointment details of cancer patients, which helps in
improved care coordination and management. The global Oncology Information
Systems Market is estimated to be valued at US$ 8.19 Bn in 2023 and is expected
to exhibit a CAGR of 6.3% over the
forecast period 2023 to 2030, as highlighted in a new report published by
Coherent Market Insights.
Market key trends:
The increased adoption of advanced technologies such as artificial
intelligence and cloud computing platforms by major players is one of the key
trends responsible for accelerating the growth of the oncology information
systems market. AI capabilities allow oncology information systems to analyze
large volumes of cancer data and provide personalized insights and
recommendations to physicians for optimizing treatment plans. Cloud-based
oncology information systems offer benefits such as lower maintenance costs,
easy access to patient health records from remote locations, and integration
with other hospital information systems. This boosts the operational efficiency
of healthcare providers and enhances cancer care outcomes. The growing
investments by players as well as governments to develop technologically
advanced oncology information solutions will continue to promote the growth of
this market over the forecast period.
Segment
Analysis
The global
oncology information systems market is dominated by the software segment. The
software segment contributed nearly 60% revenue share in the global market in
2023. Rising adoption of electronic health records and healthcare IT solutions
has propelled the demand for oncology information systems software. The
software offers efficient patient data management, treatment planning, seamless
integration with other clinical systems like radiology and laboratory
information systems. Availability of customizable software and regular software
updates by leading vendors has further increased its adoption across hospitals
and oncology clinics.
Key Takeaways
The global oncology
information systems market analysis is expected to witness high growth over
the forecast period of 2023 to 2030.
Regional analysis: North America accounted for the largest share of more than
35% of the global oncology information systems market in 2023 owing to rising
cancer burden and presence of advanced healthcare infrastructure in the region.
However, Asia Pacific is expected to witness the fastest growth during the
forecast period supported by improving healthcare infrastructure, increasing
focus on quality care, and growing adoption of health IT solutions across major
Asia Pacific countries.
Key players: Key players operating
in the global oncology information systems market include Merck & Co.,
Inc., Novartis AG, Amicus Therapeutics, AstraZeneca Plc, Boehringer Ingelheim,
Shire Plc, Sanofi Genzyme, BioMarin Pharmaceutical, Inc., Horizon Pharma Plc,
and GlaxoSmithKline Plc. Merck & Co., Inc. offers a comprehensive range of
software and solutions through its acquisition of Varian Medical Systems'
oncology solutions business in 2021. Novartis AG provides integrated software
solutions through its subsidiary Elekta to improve patient outcomes.
Comments
Post a Comment